tiprankstipranks
Trending News
More News >
Cellectar Biosciences (CLRB)
NASDAQ:CLRB
US Market
Advertisement

Cellectar Biosciences (CLRB) Technical Analysis

Compare
1,431 Followers

Technical Sentiment

Overall Consensus
Neutral
10Bullish
4Neutral
8Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Cellectar Biosciences’s (CLRB) Moving Averages Convergence Divergence (MACD) indicator is 0.16, suggesting Cellectar Biosciences is a Sell.
Cellectar Biosciences’s (CLRB) 20-Day exponential moving average is 5.25, while Cellectar Biosciences’s (CLRB) share price is $5.52, making it a Buy.
Cellectar Biosciences’s (CLRB) 50-Day exponential moving average is 5.41, while Cellectar Biosciences’s (CLRB) share price is $5.52, making it a Buy.

Cellectar Biosciences (CLRB) Pivot Points

Sep 27, 2025, 02:18 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
5.32
5.41
5.58
5.67
5.84
5.93
6.10
Fibonacci
5.41
5.51
5.57
5.67
5.77
5.83
5.93
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cellectar Biosciences (CLRB) Moving Averages

Sep 27, 2025, 02:18 PM
Period
Simple
Exponential
MA5
5.55Sell
5.54Sell
MA10
5.38Buy
5.42Buy
MA20
5.19Buy
5.25Buy
MA50
4.96Buy
5.41Buy
MA100
6.45Sell
7.40Sell
MA200
7.92Sell
14.71Sell
Cellectar Biosciences’s (CLRB) 10-Day exponential moving average is 5.42, while Cellectar Biosciences’s (CLRB) share price is $5.52, making it a Buy.
Cellectar Biosciences’s (CLRB) 100-Day exponential moving average is 7.40, while Cellectar Biosciences’s (CLRB) share price is $5.52, making it a Sell.
Cellectar Biosciences’s (CLRB) stock price is $5.52 and Cellectar Biosciences’s (CLRB) 50-day simple moving average is 4.96, creating a Buy signal.
Cellectar Biosciences’s (CLRB) stock price is $5.52 and Cellectar Biosciences’s (CLRB) 100-day simple moving average is 6.45, creating a Sell signal.
Cellectar Biosciences’s (CLRB) stock price is $5.52 and Cellectar Biosciences’s (CLRB) 200-day simple moving average is 7.92, creating a Sell signal.

Cellectar Biosciences (CLRB) Technical Indicators

Sep 27, 2025, 02:18 PM
Name
Value
Implied Action
RSI (14)
55.65
Neutral
STOCH (9,6)
70.37
Neutral
STOCHRSI (14)
76.65
Neutral
MACD (12,26)
0.16
Sell
ADX (14)
19.50
Buy
Williams %R
-38.05
Buy
CCI (14)
133.36
Sell
ATR (14)
0.40
-
Ultimate Oscillator
54.00
Neutral
ROC
9.74
Buy
Cellectar Biosciences’s (CLRB) Relative Strength Index (RSI) is 55.65, creating a Neutral signal.
Cellectar Biosciences’s (CLRB) Trend Strength Indicator (ADX) is 19.50, creating a Buy signal.
Cellectar Biosciences’s (CLRB) Commodity Channel Index (CCI) is 133.36, creating a Sell signal.
Cellectar Biosciences’s (CLRB) Price Rate of Change (ROC) is 9.74, creating a Buy signal.

FAQ

Is CLRB a Buy, Hold, or Sell?
Based on CLRB’s technical indicators, CLRB is a Hold.
    What is CLRB’s RSI (14)?
    CLRB’s RSI (14) is 55.65, which suggests CLRB is a Neutral.
      What is CLRB’s MACD?
      CLRB’s MACD is 0.16, which suggests CLRB is a Sell.
        What is CLRB’s 5-day moving average?
        CLRB’s 5-day moving average is 5.55, which suggests CLRB is a Sell.
          What is CLRB’s 20-day moving average?
          CLRB 20-day moving average is 5.19, which suggests CLRB is a Buy.
            What is CLRB’s 50-day moving average?
            CLRB’s 50-day moving average is 4.96, which suggests CLRB is a Buy.
              What is CLRB’s 200-day moving average?
              CLRB’s 200-day moving average is 7.92, which suggests CLRB is a Sell.
                What is CLRB’s Williams % R (14)?
                CLRB’s Williams % R (14) is -38.05, which suggests CLRB is a Buy.
                  What is CLRB’s CCI (14)?
                  CLRB’s CCI (14) is 133.36, which suggests CLRB is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis